Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema (2017)
- Authors:
- USP affiliated authors: MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; JORGE, RODRIGO - FMRP
- Unidade: FMRP
- DOI: 10.18240/ijo.2017.05.17
- Subjects: DIABETES MELLITUS; EDEMA MACULAR CISTOIDE; TOMOGRAFIA; DOENÇAS RETINIANAS
- Keywords: Diabetes; Macular edema; Bevacizumab; Ranibizumab; Optical coherence tomography; Central subfield foveal tickness; Diabetic retinopathy
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: International Journal of Ophthalmology
- ISSN: 2222-3959
- Volume/Número/Paginação/Ano: v. 10, n. 5, p. 760-764, 2017
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
WILLMANN, Gabriel et al. Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema. International Journal of Ophthalmology, v. 10, n. 5, p. 760-764, 2017Tradução . . Disponível em: https://doi.org/10.18240/ijo.2017.05.17. Acesso em: 20 abr. 2024. -
APA
Willmann, G., Nepomuceno, A. B., Messias, K., Barroso, L., Scott, I. U., Messias, A. M. V., & Jorge, R. (2017). Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema. International Journal of Ophthalmology, 10( 5), 760-764. doi:10.18240/ijo.2017.05.17 -
NLM
Willmann G, Nepomuceno AB, Messias K, Barroso L, Scott IU, Messias AMV, Jorge R. Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema [Internet]. International Journal of Ophthalmology. 2017 ; 10( 5): 760-764.[citado 2024 abr. 20 ] Available from: https://doi.org/10.18240/ijo.2017.05.17 -
Vancouver
Willmann G, Nepomuceno AB, Messias K, Barroso L, Scott IU, Messias AMV, Jorge R. Foveal thickeness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema [Internet]. International Journal of Ophthalmology. 2017 ; 10( 5): 760-764.[citado 2024 abr. 20 ] Available from: https://doi.org/10.18240/ijo.2017.05.17 - Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema
- Intravitreal autologous bone marrow derived stem cells in ischemic macular edema: results after 6 months follow-up
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
Informações sobre o DOI: 10.18240/ijo.2017.05.17 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
